949 stories tagged #AI

  1. Pentagon Replaces Anthropic's Claude Over Military AI Safety Restrictions
    tech

    Pentagon Replaces Anthropic's Claude Over Military AI Safety Restrictions

    The DoD tests OpenAI, Google, and Grok as alternatives to Anthropic's Claude after safety limits block lethal weapon use.

    last wk. 1 min read
  2. Anthropic Surpasses OpenAI in Annualized Revenue, Hitting $45 Billion
    tech

    Anthropic Surpasses OpenAI in Annualized Revenue, Hitting $45 Billion

    Anthropic's revenue rockets to $45B, outpacing OpenAI's $25B. Driven by enterprise adoption of Claude models and API services, the AI race has a new leader.

    last wk. 2 min read
  3. Nvidia Posts Record $81.6B Revenue, Bank of America Boosts Target
    tech

    Nvidia Posts Record $81.6B Revenue, Bank of America Boosts Target

    Nvidia reports record $81.6B quarterly revenue, with Bank of America raising its price target to $350. AI-driven data center growth dominates.

    last wk. 1 min read
  4. Standard Chartered to Cut 7,500 Jobs, Replace Them with AI by 2030
    finance

    Standard Chartered to Cut 7,500 Jobs, Replace Them with AI by 2030

    Standard Chartered plans to eliminate over 15% of corporate roles, replacing workers with AI in risk, compliance, and HR by 2030.

    2w ago 1 min read
  5. Nvidia Beats, Stock Drops: BofA Says Buy the Dip
    finance

    Nvidia Beats, Stock Drops: BofA Says Buy the Dip

    Nvidia reports record Q1 revenue of $81.6B, but stock falls. Bank of America reiterates buy with a $350 target, citing a massive AI market.

    2w ago 1 min read
  6. JPMorgan CEO Signals Major Shift: More AI, Fewer Bankers
    finance

    JPMorgan CEO Signals Major Shift: More AI, Fewer Bankers

    Jamie Dimon says JPMorgan will hire AI specialists over traditional bankers, boosting productivity and reshaping Wall Street's workforce.

    2w ago 2 min read
  7. SpaceX, OpenAI, Anthropic Near Trillion-Dollar IPO Valuations
    finance

    SpaceX, OpenAI, Anthropic Near Trillion-Dollar IPO Valuations

    Three private tech giants aim for IPOs with combined valuations rivaling Germany's GDP, raising liquidity and market concentration concerns.

    2w ago 2 min read
  8. Regeneron Leader: Europe's Clinical Trials at a Crossroads
    health

    Regeneron Leader: Europe's Clinical Trials at a Crossroads

    Muriel O'Byrne of Regeneron discusses regulatory bottlenecks, genetic breakthroughs, and leadership in clinical trials.

    2w ago 1 min read